Exploring Recent Updates in the Treatment of Breast Cancer

On September 14, 2022, William Gradishar, MD moderated a virtual workshop with fellow oncologists to discuss best practices for biomarker testing, the emerging concept of HER2-low BC, and treatment approaches for BC throughout the course of the disease. This article summarizes key takeaways and stakeholder insights from this workshop.